Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in CYTOMX THERAPEUTICS INC.
BNP PARIBAS FINANCIAL MARKETS holds 606,275 shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $2.8M as of 2026-Q1. The position was increased (+214x shares). CTMX represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$2.8M
Current Shares
606,275
Total Value Change
+$2.8M
Total Shares Change
+606,197
Other major holders of CTMX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 606,275 |
+214x |
| $2.8M |
| 0.0% |
| $4.81 |
42 |
| 2025-Q4 | Increased | 2,825 | +165x | $12,034 | 0.0% | $4.16 | 19 |
| 2025-Q3 | Unchanged | 17 | 0.0% | $54 | 0.0% | $3.23 | 0 |
| 2025-Q2 | Unchanged | 17 | 0.0% | $39 | 0.0% | $2.25 | 0 |
| 2025-Q1 | Decreased | 17 | -78.2% | $11 | 0.0% | $0.63 | 0 |
| 2024-Q4 | Decreased | 78 | -59.8% | $80 | 0.0% | $1.02 | 0 |
| 2024-Q3 | Increased | 194 | +148.7% | $229 | 0.0% | $1.20 | 12 |
| 2024-Q2 | Unchanged | 78 | 0.0% | $95 | 0.0% | $1.22 | 0 |